T-cells, their subsets and function are profoundly altered in CLL and known to be of pathological relevance, as recently reviewed by us (46), emphasizing the need to evaluate the effect of PI3K inhibitors on these cells. The gene discussed is PIK3CA; the disease is B-cell chronic lymphocytic leukemia.